can compounded tirzepatide still be sold Impurity in Some 'Potentially Dangerous,' Eli Lilly Warns COMPOUNDED TIRZEPATIDE

Clinical trials of semaglutide showed participants lost 1022% of their body weight over 68 weeks, depending on the dose and individual metabolic response

A new real-world study from Embla, presented at the European Congress on Obesity (ECO) 2025 , shows that our members lost an average of 16.7% of their body weight after 64 weeks using less than half the standard dose of semaglutide (Wegovy) typically used in clinical trials

Both medications reduce appetite through different mechanisms, and combining them could increase side effects without proportionally better results

Tirzepatide has a long half-life of roughly five days, which gives you some flexibility if you miss your usual injection day